Important Announcements

Nondiscrimination Policy Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To read our full Nondiscrimination Statement, click here.

Sickle cell disease (SCD) is a life-limiting condition and the most common genetic disease among African Americans, affecting approximately 100,000 individuals in the United States. The pulmonary complications of sickle cell disease, which are in themselves associated with high levels of acute and chronic morbidity and early mortality, are poorly understood, understudied, and under-recognized by clinicians. Through Dr. Robyn Cohen’s collaboration with the multicenter Sleep and Asthma Cohort research group, she demonstrated that features of asthma (recurrent wheezing, airway obstruction and inflammation, and atopy) are common among children with sickle cell anemia and associated with significant morbidity. Current projects involve evaluating the impact and effectiveness of using BiPAP as supportive care for hospitalized individuals with SCD. 

See all of our Pediatric Research programs.

Contact

Robyn Cohen, MD, MPH: Robyn.Cohen@bmc.org

Investigators

Research projects

  1. SNAP: Supportive Non-invasive Ventilation for Acute Chest Syndrome Prevention in Hospitalized Children with Sickle Cell Disease, 1UL1TR001430
  2. IMPROVE 2: Inhaled Mometasone to Promote Reduction in Vaso-Occlusive Events, R01HL142671
  3. The Pro-Inflammatory Effects of Acute Exercise in Children with Sickle Cell Anemia, R01HL136480